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SUMMARY 
In rat brain, 3H-EKC shows a relat ive regional distribution of 
binding which parallels that of 3H-morphine. Dynorphin(1-13) has 
a pattern similar to morphine and dissimilar to EKC in displacing 
the three labels. Dynorphin(1-13) is mo~e potent against 
3H-morphine than against 3H-EKC across brain regions while 
B-endorphin competes better against 3H-EKC. 
Several classes of opiate receptor~exist in the mamalian CNS (1,2); the 
~, 5, and k receptors have been best characterized by pharmacologic assaysx 
The prototypical agonists for each of these receptors are morphine, [d-ala z, 
d-leub]-enkephalin (DADLE), and ethylketocyclazocine (EKC) respectively. 
Our work to date (3) suggests that the ~ and a sites have dif ferent distr ibu- 
tions in rat brain and that the enkephalins interact preferential ly with the 
6 receptor while B-endorphin can interact at both the ~ and 6 sites, having a 
s l ight ly greater preference for a. The interaction of opioid peptides with 
the k site has not been well studied in CNS tissues, however, dynorphin 
reportedly interacts with the k receptor in guinea pig ilium and brain (4). 
To characterize the interaction of the endogenous peptides with the 
different opiate receptors, part icularly the k opiate receptor, we examine 
the ab i l i t y  of dif ferent opiates to inhibi t  the binding of 3H-EKC~ the 
prototypical k ligand, and compare that with the displacement of H-DADLE 
and 3H-morphine. Statements of d i f ferent ia l  potencies are based on 
relative potencies against all three 3H-ligands in the same brain regional 
preparations. This approach allows us to characterize the different opioid 
peptides as being more morphine-like (~), more enkephalin-like (a), or more 
EKC-like (k). 
METHODS 
Brain regions of male Sprague-Dawley rats (160-200 g) were dissected on 
ice and homogenized by a polytron in cold 50 mM TRIS.HCL pH 7.4 at 50 mg/ml 
for 40 sec. Each homogenate was preincubated at 37 ° for 40 min, centrifuged 
at 30,000 g for 20 min, resuspended in buffer at 50 mg/ml, incubated for 40 
min at 25°C for 2 hr with a 1 nM concentration of t r i t ia ted  ligand and 3-7 
concentrations of unlabeled ligand. Total incubation volumn was 500 ul. 
Homogenates were thep diluted with 4.5 mls cold buffer, f i l tered,  and rinsed 
with 4.5 mls cold buffer. Membrane bound radioactivit~ was assessed by 
sc int i l la t ion counting. Specific binding for a given ~H-ligand was 
defined as total binding minus binding in the presence of I~M concentration 
of corresponding unlabeled ligand. Each estimate of specific displacement 
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TABLE I. 
REGIONAL BINDING - 3H-EKC 
SEM N R(3~-DADLE~  ~,3H-MOR 
~H-EKC ' K t ~ J  
Striatum 2.9 .20 11 1.5 1.3 
F. Cortex 2.3 .20 7 1.4 1.3 
Hippocampus 1.7 .09 11 1.0 1.4 
Hypothalamus 1.5 .07 12 0.6 1.1 
Midbrain 1.6 .08 11 0.6 1.3 
Whole Brain 1.3 .10 6 1.3 1.6 
SPECIFIC BINDING OF I NM 3H-EKC IN BRAIN REGIONS AND WHOLE BRAIN. 
Values represent the average specific binding in fmols/mg region (wet 
wt) for 1 nM 3H-EKC incubated with 30 mg/ml concentration of membrane 
preparation at 4°C. 
is the average of 2-4 replicates within a given experiment. Each experiment 
compares the displacement of at least two ~H-ligands by at least two 
unlabeled ligands in the same regional preparations. In a given experiment 
4-5 regions were tested simultaneously. IC50 values were determined by 
plots of percent control specific binding versus log concentration of cold 
ligand. Mean IC50 values and standard errors were computed using log 
transformed IC50 values from different experiments. 
RESULTS 
The ordering of regional binding for 3H-EKC is the same as that seen 
in our studies with 3H-morphine and 3H-DADLE (3); striatum and frontal 
cortex contain the highest levels of 3H-EKC binding followed by hippo- 
campus, midbrain, and hypothalamus (Table I).  Remaining brain regions as a 
whole contain only 0.6 fmol specific binding per mg tissue. Scatchard 
analysis of 3H-EKC binding in whole brain yields a linear plot with an 
af f in i ty  (Kd) of 10 nM. While the ratio of 3H-EKC to 3H-DADLE binding 
varies by a factor of almost three over these five brain regions, the ratio 
of 3H-EKC to 3H-morphine binding remains almost constant across brain 
regions. In competition studies (Table I I ) ,  DADLE is the least potent ligand 
in displacing ~H-EKC binding in every region and is less than one-third as 
potent in hypothalamus as i t  is in hippocampus. SKF 10,047, dynorphin(1-13), 
and B-endorphin are the most potent ligands against 3H-EKC. To determine 
whether dynorphin(1-13) is more R-like or k-like in the rat CNS, we compare 
its potencies against the three ~H-ligands with those of morphine and EKC 
(Figure 1). Unlabeled EKC shows remarkably similar potencies against all 
three labels across regions. Unlabeled dynorphin(1-13) shows a pattern of 
displacement of the three labels which is similar to that of unlabeled 
morphine. I t  is more potent against 3H-morphine than against 3H-EKC in 
each of the five regions and in whole brain. Like unlabeled morphine i t  is 
weakest against 3H-DADLE across regions. 
To more closely examine the preferences of the representative opioid 
peptides for the opiate receptor types, we calculate the ratio of potencies 
of the unlabeled peptides against 1 nM concentrations of 3H-morphine and 
3H-EKC, and 3H-DADLE and 3H-EKC. The use of potency ratios has the 
effect of controlling for region-specific effects such as differential 
regional occupancy and regional breakdown. In our whole brain membrane 
preparation, dynorphin(1-13) is 1.4 times more potent against 3H-morphine 
than 3H-EKC. Figure 2a demonstrates that dJmorphin(1-13) is more effective 
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TA3BLE I I. H-EKC 
Log Average IC50 Values 
IC50 LSEM N 
Morphine 
Striatum 12 .054 4 
F. Cortex 4.8 .128 2 
Hippocampus 4.6 .078 4 
Hypothalamus 9.9 .097 4 
Midbrain 11 .063 4 
IC50 LSEM N IC50 LSEM N 
DADLE Dynorphin(1-13) 
19 .041 5 2.9 .049 4 
19 .033 2 1.8 .014 3 
16 .081 3 2.3 .036 4 
50 .038 3 2.7 .048 5 
41 .126 3 2.7 .016 4 
B-Endorphin EKC SKF 
Striatum 2.4 .075 2 8.4 .056 4 3.4 .023 4 
F. Cortex 2.1 .087 3 9.2 .066 4 3.0 .038 4 
Hippocampus 1.6 .055 4 6.4 .110 4 2.5 .027 4 
Hypothalamus 3.2 .094 3 12 .025 2 2.6 .125 4 
Midbrain 3.4 .048 4 17 .080 4 4.6 .036 3 
POTENCIES {NM) OF OPIATES AND OPIOID PEPTIDES AGAINST 3H-EKC IN BRAIN 
REGIONS. 3H_EKC (lnM) was incubated with 3-7 concentrations of 
unlabeled ligand. IC50 values were determined by plots of percent 
control specific binding versus log concentration of cold ligand. 
IC50 values given represent the log average of the IC50 values of 
(N) experiments and are expressed in nM units of concentration. 
Standard errors are expressed in log units (LSEM). 
across brain regions against 3H-morphine than against 3H-EKC. In contrast, 
B-endorphin is more effective across brain regions against 3H-EKC. When 
comparisons are made against 3H-EKC and 3H-DADLE (Figure 2b), dynorphin(1-13) 
shows a preference for 3H-EKC labeled sites. B-endorphin is nearly equipo- 
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~ OMPARISON OF POTENCIES OF MORPHINE, DYNORPHIN(1-13), AND EKC AGAINST 
H-OPIATES IN BRAIN REGIONS. Concentration curves of morphine, 
dynorphin(1-13), and EKC were run against 1 nM concentrations of the 
three ~H-opiates in the same brain regional preparations. 
10 
DISCUSSION 
Our purpose in these studies has been to determine the interaction of the 
opioid peptides with dif ferent opiate receptor types in the rat CNS and to 
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RATIOS OF POTENCIES OF OPIOID PEPTIDES AGAINST 1NM 3H-OPIATE LIGANDS. 
Concentration curves of DADLE, ~-endorphin, and dynorphin(1-13) were run 
against 1 nM concentrations of H-morphine and JH-EKC in (a), and 
JH-DADLE and 3H-EKC in (b), both in the same brain region preparations. 
seek evidence for a receptor with k properties in regional preparations of 
rat brain. We find, however, no evidence for a specific k receptor in these 
brain regions, but find that the k prototype JH-EKC shows a binding d i s t r i -  
bution which parallels the distribution of JH-morphine labeled sites. The 
putative k peptide, dynorphin(1-13), displaces the opiate labels with a 
pattern of inhibit ion which is similar to that of unlabeled morphine and 
different from that of unlabeled EKC. The u-like character of d~n~orphin 
(1-13) is further demonstrated by its rat io of potencies against JH-morphine 
and 3H-EKC. I t  is more potent against 3H-morphine ~cross brain regions 
while the other two peptides show a preference for H-EKC labeled sites. 
These data are consistent with the hypothesis that there are few k sites 
in the rat CNS, in particular, in these five brain regions. Thus, in the rat 
brain, 3H-EKC may be predominately labeling u and 6 sites with a preference 
for u sites. B-Endorphin, which also interacts well with both ~ and ~ sites, 
does better at displacing 3H-EKC than do either dynorphin(1-13) or DADLE, 
which are weak at the 6 site and ~ si te, respectively. Dynorphin(1-13) 
displaces 3H-morphine more easily than 3H_EKC since the lat ter binds to 
the 6 site for which dynorphin has a low af f in i ty .  Whereas in the guinea pig 
CNS dynorphin may act as a k ligand, our data suggest that this same peptide 
may act predominately as a u ligand in the central nervous system of the rat. 
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